ATE464374T1 - Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen - Google Patents
Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegenInfo
- Publication number
- ATE464374T1 ATE464374T1 AT01977357T AT01977357T ATE464374T1 AT E464374 T1 ATE464374 T1 AT E464374T1 AT 01977357 T AT01977357 T AT 01977357T AT 01977357 T AT01977357 T AT 01977357T AT E464374 T1 ATE464374 T1 AT E464374T1
- Authority
- AT
- Austria
- Prior art keywords
- highly specific
- activated protein
- assay
- specific monoclonal
- monoclonal antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96461—Protein C (3.4.21.69)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23748100P | 2000-10-02 | 2000-10-02 | |
| PCT/US2001/030802 WO2002029015A1 (en) | 2000-10-02 | 2001-10-02 | Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE464374T1 true ATE464374T1 (de) | 2010-04-15 |
Family
ID=22893898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01977357T ATE464374T1 (de) | 2000-10-02 | 2001-10-02 | Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6989241B2 (de) |
| EP (1) | EP1322749B1 (de) |
| AT (1) | ATE464374T1 (de) |
| AU (2) | AU9648301A (de) |
| DE (1) | DE60141844D1 (de) |
| WO (1) | WO2002029015A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1460414B1 (de) * | 2001-12-27 | 2018-09-19 | ARKRAY, Inc. | Konzentrationsmessverfahren |
| US8658773B2 (en) | 2011-05-02 | 2014-02-25 | Immunomedics, Inc. | Ultrafiltration concentration of allotype selected antibodies for small-volume administration |
| US7902338B2 (en) | 2003-07-31 | 2011-03-08 | Immunomedics, Inc. | Anti-CD19 antibodies |
| ES2268961B1 (es) * | 2005-03-17 | 2008-03-16 | Proyecto De Biomedicina Cima, S.L. | Nueva proteina epcr soluble de origen no proteolitico y su uso. |
| DE102007041476B4 (de) | 2007-08-31 | 2017-03-30 | Rheinische Friedrich-Wilhelms-Universität Bonn | Aptamere, die an ein an der Hämostase beteiligtes Zielmolekül binden |
| AU2016203760B2 (en) * | 2007-10-26 | 2017-12-21 | Oklahoma Medical Research Foundation | Monoclonal antibodies against activated and unactivated protein c |
| WO2009055669A2 (en) * | 2007-10-26 | 2009-04-30 | Oklahoma Medical Research Foundation | Monoclonal antibodies against activated and unactivated protein c |
| AU2015200348B2 (en) * | 2007-10-26 | 2016-04-14 | Oklahoma Medical Research Foundation | Monoclonal antibodies against activated and unactivated protein c |
| US20100081924A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
| US20100081926A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
| US20100081916A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware. | Histological facilitation systems and methods |
| US20100081915A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, Alimited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
| US20100081927A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
| US20160095939A1 (en) | 2014-10-07 | 2016-04-07 | Immunomedics, Inc. | Neoadjuvant use of antibody-drug conjugates |
| ES3000111T3 (en) | 2009-02-13 | 2025-02-27 | Immunomedics Inc | Intermediates for preparing conjugates with an intracellularly-cleavable linkage |
| EP2478110B1 (de) | 2009-09-16 | 2016-01-06 | Immunomedics, Inc. | Klasse-i-anti-cea-antikörper und verwendungen davon |
| ES2978177T3 (es) | 2009-12-02 | 2024-09-06 | Immunomedics Inc | Combinación de radio inmunoterapia y conjugados anticuerpo-fármaco para mejorar la terapia contra el cáncer |
| CN104379169A (zh) | 2012-08-14 | 2015-02-25 | Ibc药品公司 | 用于治疗疾病的t-细胞重定向双特异性抗体 |
| MX2015006738A (es) * | 2012-11-29 | 2015-08-05 | Bayer Healthcare Llc | Anticuerpos monoclonales humanizados contra la proteina c activada y sus usos. |
| WO2014085596A1 (en) * | 2012-11-29 | 2014-06-05 | Bayer Healthcare Llc | MONOCLONAL ANTIBODIES AGAISNT ACTIVATED PROTEIN C (aPC) |
| CN107753954A (zh) | 2012-12-13 | 2018-03-06 | 免疫医疗公司 | 功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量 |
| WO2017004144A1 (en) | 2015-07-01 | 2017-01-05 | Immunomedics, Inc. | Antibody-sn-38 immunoconjugates with a cl2a linker |
| JP6447933B2 (ja) | 2014-02-21 | 2019-01-09 | アイビーシー ファーマスーティカルズ，インコーポレイテッド | Ｔｒｏｐ−２発現細胞に対する免疫応答を誘発することによる疾患治療 |
| CA2935748A1 (en) | 2014-02-25 | 2015-09-03 | Immunomedics, Inc. | Humanized rfb4 anti-cd22 antibody |
| EP3160504B1 (de) | 2014-06-24 | 2020-09-16 | Immunomedics, Inc. | Antihistontherapie für vaskuläre nekrose bei schwerer glomerulonephritis |
| AU2016252771B2 (en) | 2015-04-22 | 2021-12-16 | Immunomedics, Inc. | Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells |
| JP6980980B2 (ja) | 2015-06-25 | 2021-12-15 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | 抗ｈｌａ‐ｄｒまたは抗ｔｒｏｐ‐２抗体と微小管阻害剤、ｐａｒｐ阻害剤、ブルトンキナーゼ阻害剤またはホスホイノシチド３‐キナーゼ阻害剤との併用は癌の治療効果を有意に改善する |
| WO2017087391A1 (en) | 2015-11-17 | 2017-05-26 | Bayer Healthcare, Llc | Epitope of optimized humanized monoclonal antibodies against activated protein c and uses thereof |
| WO2022239720A1 (ja) | 2021-05-10 | 2022-11-17 | 公益財団法人川崎市産業振興財団 | 抗原への結合親和性を低減させた抗体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0287028B1 (de) | 1987-04-17 | 1993-07-21 | Teijin Limited | Verfahren zur Trennung von aktiviertem menschlichem Protein C |
| JPH03200066A (ja) | 1989-12-28 | 1991-09-02 | Tosoh Corp | 活性化ヒトプロテインｃの測定方法 |
-
2001
- 2001-10-02 AT AT01977357T patent/ATE464374T1/de not_active IP Right Cessation
- 2001-10-02 WO PCT/US2001/030802 patent/WO2002029015A1/en not_active Ceased
- 2001-10-02 DE DE60141844T patent/DE60141844D1/de not_active Expired - Lifetime
- 2001-10-02 US US10/398,063 patent/US6989241B2/en not_active Expired - Fee Related
- 2001-10-02 EP EP01977357A patent/EP1322749B1/de not_active Expired - Lifetime
- 2001-10-02 AU AU9648301A patent/AU9648301A/xx active Pending
- 2001-10-02 AU AU2001296483A patent/AU2001296483B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE60141844D1 (de) | 2010-05-27 |
| EP1322749A1 (de) | 2003-07-02 |
| AU9648301A (en) | 2002-04-15 |
| US20040014138A1 (en) | 2004-01-22 |
| WO2002029015A9 (en) | 2003-09-12 |
| WO2002029015A1 (en) | 2002-04-11 |
| EP1322749B1 (de) | 2010-04-14 |
| US6989241B2 (en) | 2006-01-24 |
| AU2001296483B2 (en) | 2006-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE464374T1 (de) | Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen | |
| DK2316852T3 (da) | Stabiliserede enkeltdomæne-antistoffer | |
| FR2794865B1 (fr) | Methode de detection precoce des flavivirus et ses applications | |
| CY1123400T1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| NO20054351L (no) | Monoklonalt antistoff og hybridom som produserer dette | |
| DK1565489T3 (da) | Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet | |
| EP0914155A4 (de) | Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen | |
| WO2004041865A3 (en) | Stabilized single domain antibodies | |
| CY1109645T1 (el) | Ανθρωπινος πρωτεϊνικος υποδοχεας τυπου toll, σχετικα αντιδραστηρια και μεθοδοι | |
| BRPI0413495A (pt) | reagentes de peptìdeos especìficos para prìons e seus usos | |
| CY1108545T1 (el) | Πρωτεϊνες υπομοναδας υποδοχεα κυτοκινης θηλαστικου, σχετικα αντιδραστηρια και μεθοδοι | |
| HUP0301877A2 (hu) | Aromatáz inhibitorok és monoklonális anti-HER2 ellenanyagok mint tumorellenes szerek | |
| ATE459706T1 (de) | Monoklonales antikörper gegen das hcv kernantigen | |
| WO2004035742A3 (en) | Sets of digital antibodies directed against short epitopes, and methods using same | |
| WO2005120166A3 (en) | Antibodies for selective apoptosis of cells | |
| WO2005080985A3 (en) | Methods and compositions for detecting and treating autoimmune diseases | |
| DE60045870D1 (de) | Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit | |
| WO2007001737A3 (en) | Methods and compositions for detecting herpes simplex virus type 2 | |
| CY1106349T1 (el) | Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c | |
| BR0314166B8 (pt) | teste de hcv | |
| ATE408832T1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
| WO2006020263A3 (en) | Cytoxan antibodies and immunoassay | |
| HU0100948D0 (en) | Antibody competiton binding assay for qualitative detection of the conformation changes and conformation-dependent quantitative detection of glycoprotein p and other cell surface receptors, pumps and proteins, and use thereof | |
| ATE324380T1 (de) | Monoklonale antikörper gegen s100 | |
| EP1483292A4 (de) | Mit bakteriellen collagen-bindenden proteinen kreuzreaktive monoklonale antikörper |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |